Duff H J, Mitchell L B, Nath C F, Manyari D E, Baynton R, Wyse D G
Department of Medicine, University of Calgary, Alberta, Canada.
Clin Pharmacol Ther. 1989 May;45(5):542-7. doi: 10.1038/clpt.1989.70.
The protein binding of disopyramide is altered when concentration is increased within the therapeutic range. A wide range of free concentrations may be produced at a given total concentration. The present study assessed whether intracardiac electrophysiologic responses to disopyramide related better to free or to total concentration. Intravenous infusions of disopyramide were evaluated in 17 patients with inducible sustained ventricular tachycardia. The first maintenance infusion produced total serum concentrations of 11.7 +/- 2 mumols/L, and no significant increase occurred at higher-dose infusions. However, free concentrations during the first and second maintenance infusions were significantly different at 5.3 +/- 1 mumols/L and 6.8 +/- 1 mumols/L, respectively. Free fraction also increased significantly, from 45% +/- 8% to 50% +/- 7%. Overall change in QTc interval and ventricular tachycardia cycle length correlated with free concentration but not with total concentration. This study showed that some intracardiac measurements correlate with free concentration but that none correlate with total concentration.
当丙吡胺的浓度在治疗范围内增加时,其蛋白结合率会发生改变。在给定的总浓度下,可能会产生广泛的游离浓度范围。本研究评估了丙吡胺的心脏内电生理反应与游离浓度还是总浓度的相关性更好。对17例可诱发持续性室性心动过速的患者进行了丙吡胺静脉输注评估。首次维持输注产生的血清总浓度为11.7±2μmol/L,高剂量输注时未出现显著增加。然而,首次和第二次维持输注期间的游离浓度分别为5.3±1μmol/L和6.8±1μmol/L,存在显著差异。游离分数也显著增加,从45%±8%增至50%±7%。QTc间期和室性心动过速周期长度的总体变化与游离浓度相关,但与总浓度无关。本研究表明,一些心脏内测量值与游离浓度相关,但与总浓度均无相关性。